Abstract:The gut immune system in the healthy intestine is anti-inflammatory, but can move to a pro-inflammatory state when the gut is challenged by pathogens or in disease. The nervous system influences the level of inflammation through enteric neurons and extrinsic neural connections, particularly vagal and sympathetic innervation of the gastrointestinal tract, each of which exerts anti-inflammatory effects. Within the enteric nervous system (ENS), three neuron types that influence gut immune cells have been identified, intrinsic primary afferent neurons (IPANs), vasoactive intestinal peptide (VIP) neurons that project to the mucosa, and cholinergic neurons that influence macrophages in the external muscle layers. The enteric neuropeptides, calcitonin gene-related peptide (CGRP), tachykinins, and neuromedin U (NMU), which are contained in IPANs, and VIP produced by the mucosa innervating neurons, all influence immune cells, notably innate lymphoid cells (ILCs). ILC2 are stimulated by VIP to release IL-22, which promotes microbial defense and tissue repair. Enteric neurons are innervated by the vagus, and, in the large intestine, by the pelvic nerves. Vagal nerve stimulation reduces gut inflammation, which may be both by stimulation of efferent (motor) pathways to the ENS, and stimulation of afferent pathways that connect to integrating centers in the CNS. Efferent pathways from the CNS have their anti-inflammatory effects through either or both vagal efferent neurons and sympathetic pathways. The final neurons in sympathetic pathways reduce gut inflammation by the action of noradrenaline on β2 adrenergic receptors expressed by immune cells. Activation of neural anti-inflammatory pathways is an attractive option to treat inflammatory bowel disease that is refractory to other treatments. Further investigation of the ways in which enteric reflexes, vagal pathways and sympathetic pathways integrate their effects to modulate the gut immune system and gut inflammation is needed to optimize neuromodulation therapy.

A neurotransmitter system that regulates macrophage pro-inflammatory functions

A1609 Microglia Regulate Sympathetic PVN Neuronal Activity in Both Resting and Hypertensive States

Adrenergic signaling regulation of macrophage function: do we understand it yet?

Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia

Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases

Adaptor molecules mediate negative regulation of macrophage inflammatory pathways: a closer look

Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets

Catecholamines Attenuate LPS-Induced Inflammation through β2 Adrenergic Receptor Activation- and PKA Phosphorylation-Mediated TLR4 Downregulation in Macrophages

Regulation of pain by neuro-immune interactions between macrophages and nociceptor sensory neurons

Functional characterization of the biogenic amine transporters on human macrophages

What Is the Role of Microglial Metabolism in Inflammation and Neurodegeneration?

[Research Advances on Adrenergic Receptor Signaling Involved in Disease Microenvironment Through Regulation of Macrophages].

Neuronal regulation of the gut immune system and neuromodulation for treating inflammatory bowel disease

Cholinergic modulation of the immune system presents new approaches for treating inflammation

Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia

The potential for treg-enhancing therapies in nervous system pathologies

Research Progress on the Role of Microglia Membrane Proteins or Receptors in Neuroinflammation and Degeneration

Phytochemicals as modulators of M1-M2 macrophages in inflammation

Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases